Greg Jefferys Hepatitis C blog deals with all the issues associated with hepatitis C
Since 2014 when I learned that I was infected with Hepatitis C the single BIG issue has been the price of Hepatitis C treatment. Back in 2014 the only treatment option was Sovaldi or Interferon. Sovaldi cost US$84,000 for a 12 week treatment and Interferon cost about US$40,000 for a treatment.
I could not afford Sovaldi and there was no way I would consider doing the Interferon treatment; my only option was to manage my Hep C through lifestyle choices.
Fortunately for me generic Sovaldi was released in India in May 2015 and I was able to afford the $1,000 for the treatment plus the extra $2,000 it cost me to fly to India and stay there for a week to get the Sovaldi.
This experience made me acutely aware of how critical the pricing of Hepatitis C drugs was for people who had Hepatitis C and did not have access to the medication through some form of health insurance.
Since 2015 I have dedicated my life to making affordable Hepatitis C treatment available to people. Initially this was to people in “First World” countries like Australia, the USA and Europe, however as my work expanded I became more and more aware of how difficult things were for impoverished people with Hepatitis C.
For people in impoverished situations even the relatively low cost of generic Hepatitis C medication is beyond their reach.
Poor people living in poverty have no disposable income, they have no spare money to save. This applies whether they are poor people in rich countries or poor people in poor countries. Every bit of their income goes to meeting the basic requirements of living; food and shelter.
For these people even the $550 for 12 weeks of generic Sovaldi and Daklinza in an unreachable amount of money.
Go Fund Me: A Genuine Chance to Change the World
There are probably more than 100 million people on the Earth infected with Hepatitis C (exact figures are difficult to obtain from many countries).
At least 70 million of those people live in situations where they can not access Hepatitis C treatment because the cost is too high.
Almost one million people will die from Hepatitis C related causes every year.
Many millions more will sicken and suffer because they can not afford treatment.
Currently brand versions of Hepatitis C drugs cost between US$25,000 and US$90,000 per treatment while generic Hepatitis C medicines cost between US$500 and US$1,500 per treatment.
The purpose of this project is to reduce that price to under US$250 for a 12 week treatment.
This project is to raise enough money to buy one thousand (1,000) Hepatitis C treatments so that I can supply a 12 week treatment of Hep C medicine for under US$250 per treatment.
This price would include the medication and all associated costs such as shipping and handling and other necessary documentation.
How the Global Hep C Support Project Will Work
I have already negotiated a price for one thousand Hep C treatments with a licensed supplier of generic Hepatitis C medicine. Once I have raised US$150,000 I will purchase the 1,000 treatments and begin to make them available to people in impoverished situations across the world.
I will supply the pan-genotype treatment of Sofosbuvir 400 mg + Daclatasvir 60 mg. This treatment is effective against all genotypes of Hepatitis C. This will be supplied for under US$250 including shipping and all other costs.
Sustainable Hepatitis C Support
Because this medication will be sold at cost rather than given away for free the funds raised in this program will continue to purchase Hepatitis C medication for many years into the future. In other words the money raised will not just buy one thousand Hep C treatments, the money raised will buy hundreds of thousands of Hep C treatments… maybe even millions of Hep C treatment.
The way it will work is that once a few hundred treatments have been sold that money will be used to buy more treatments. As Hep C treatments are sold they will be replaced, so the pool of low cost treatments will never diminish. This means the project is sustainable in the long term and has the potential to treatment millions of people.
It would be expected that as volumes increase our purchase price will decrease and it would be my hope and expectation that within a year or two the Global Hepatitis C Support project will be able to supply Hep C treatments for under US$150 for a 12 weeks treatment.
The Global Hep C Support Project will work in cooperation, on a local level, with doctors and nurses and other health providers.
None of this money raised will be touched until enough money has been raised to purchase 1,000 treatments.
Because the treatments will be sold at cost price it will mean that your donation will continue to provide Hepatitis C treatments for people in impoverished situations for years, or until Hepatitis C has been eliminated from the planet.
This is a genuine chance to challenge the domination of the world’s medication supplies by Big Pharma. This is a chance to initiate real, and lasting, change.
To put the target amount of US$150,000 into perspective:
This US$150,000 is less than the cost of two treatments of Epclusa in the USA
This US$150,000 is less than the weekly pay of GILEAD’s CEO John F. Milligan who made $25,961,831 in total compensation for the 2018 fiscal year.
This is less than 5% of the annual budget of World Hepatitis Alliance, the NGO pretending to be dedicated to the global eradication of Hepatitis C, but which is funded by Big Pharma and has no real interest in providing low cost access to Hepatitis C treatment.